Purinoreceptor-mediated current in myocytes from renal resistance arteries

British Journal of Pharmacology

Volumn 160, Issue 4, 2010, Pages 987-997

  Harhun, Maksym I ^a   Povstyan, Oleksandr V ^a,b   Gordienko, Dmitri V ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b BOGOMOLETZ INSTITUTE OF PHYSIOLOGY   (Ukraine)

Author keywords

Artery; ATP; Heteromeric P2X1 4 receptors; Kidney; NF279; P2X1 receptors; P2X4 receptors; Renal vascular smooth muscle cells; meATP

Indexed keywords

8,8' [CARBONYLBIS[IMINO 4,1 PHENYLENECARBONYLIMINO 4,1 PHENYLENECARBONYL IMINO]]BIS(1,3,5 NAPHTHALENE TRISULPHONIC ACID); ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; AMPHOTERICIN B; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X4 RECEPTOR; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ALPHA,BETA-METHYLENEADENOSINE 5'-TRIPHOSPHATE; MESSENGER RNA; NF 279; P2RX4 PROTEIN, RAT; PURINERGIC P2 RECEPTOR; PURINERGIC P2 RECEPTOR AGONIST; PURINERGIC P2 RECEPTOR ANTAGONIST; SURAMIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TARGETING; ION CURRENT; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; MALE; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MUSCLE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESISTANCE BLOOD VESSEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; SYMPATHETIC FUNCTION; VASCULAR SMOOTH MUSCLE; VOLTAGE CLAMP; ANALOGS AND DERIVATIVES; ANIMAL; ANTIBODY SPECIFICITY; ARTERY; CYTOLOGY; DRUG EFFECTS; GENETICS; KIDNEY; KINETICS; METABOLISM; MICRODISSECTION; OSMOLARITY; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; VASCULARIZATION; WISTAR KYOTO RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARTERIES; KIDNEY; KINETICS; MALE; MEMBRANE POTENTIALS; MICRODISSECTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; OSMOLAR CONCENTRATION; PATCH-CLAMP TECHNIQUES; PURINERGIC P2 RECEPTOR AGONISTS; PURINERGIC P2 RECEPTOR ANTAGONISTS; RATS; RATS, INBRED WKY; RECEPTORS, PURINERGIC P2; RECEPTORS, PURINERGIC P2X; RECEPTORS, PURINERGIC P2X4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURAMIN;

EID: 77952869988     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00714.x     Document Type: Article

References (59)

1. Alexander SP, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th Edition. Br J Pharmacol 158 (Suppl 1 S1 S254.
2. Bao JX, Stjarne L (1993). Dual contractile effects of ATP released by field stimulation revealed by effects of alpha,beta-methylene ATP and suramin in rat tail artery. Br J Pharmacol 110 : 1421 1428.
3. Bell PD, Lapointe JY, Sabirov R, Hayashi S, Peti-Peterdi J, Manabe K et al 2003). Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci U S A 100 : 4322 4327.
4. Benham CD, Bolton TB, Lang RJ, Takewaki T (1986). Calcium-activated potassium channels in single smooth muscle cells of rabbit jejunum and guinea-pig mesenteric artery. J Physiol 371 : 45 67.
5. Bo X, Burnstock G (1995). Characterization and autoradiographic localization of [3H] alpha, beta-methylene adenosine 5′-triphosphate binding sites in human urinary bladder. Br J Urol 76 : 297 302.
6. Burnstock G (1972). Purinergic nerves. Pharmacol Rev 24 : 509 581.
7. Cario-Toumaniantz C, Loirand G, Ladoux A, Pacaud P (1998). P2X7 receptor activation-induced contraction and lysis in human saphenous vein smooth muscle. Circ Res 83 : 196 203.
8. Chan CM, Unwin RJ, Bardini M, Oglesby IB, Ford AP, Townsend-Nicholson A et al. (1998). Localization of P2X1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274 : F799 F804.
9. Cupples WA, Braam B (2007). Assessment of renal autoregulation. Am J Physiol Renal Physiol 292 : F1105 F1123.
10. Damer S, Niebel B, Czeche S, Nickel P, Ardanuy U, Schmalzing G et al. (1998). NF279: a novel potent and selective antagonist of P2X receptor-mediated responses. Eur J Pharmacol 350 : R5 R6.
11. DiBona GF (2004). The sympathetic nervous system and hypertension: recent developments. Hypertension 43 : 147 150.
12. DiBona GF, Kopp UC (1997). Neural control of renal function. Physiol Rev 77 : 75 197.
13. DiBona GF, Sawin LL (2004). Effect of renal denervation on dynamic autoregulation of renal blood flow. Am J Physiol Renal Physiol 286 : F1209 F1218.
14. Evans RJ, Surprenant A (1992). Vasoconstriction of guinea-pig submucosal arterioles following sympathetic nerve stimulation is mediated by the release of ATP. Br J Pharmacol 106 : 242 249.
15. Evans RJ, Lewis C, Buell G, Valera S, North RA, Surprenant A (1995). Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol Pharmacol 48 : 178 183.
16. Evans RJ, Lewis C, Virginio C, Lundstrom K, Buell G, Surprenant A et al 1996). Ionic permeability of, and divalent cation effects on, two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol 497 (Pt 2 413 422.
17. Galligan JJ, Herring A, Harpstead T (1995). Pharmacological characterization of purinoceptor-mediated constriction of submucosal arterioles in guinea pig ileum. J Pharmacol Exp Ther 274 : 1425 1430.
18. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C et al. (1991). Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138 : 867 873.
19. Gordienko DV, Clausen C, Goligorsky MS (1994). Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol 266 : F325 F341.
20. Grady HC, Bullivant EM (1992). Renal blood flow varies during normal activity in conscious unrestrained rats. Am J Physiol 262 : R926 R932.
21. Guan Z, Osmond DA, Inscho EW (2007a). P2X receptors as regulators of the renal microvasculature. Trends Pharmacol Sci 28 : 646 652.
22. Guan Z, Osmond DA, Inscho EW (2007b). Purinoceptors in the kidney. Exp Biol Med (Maywood) 232 : 715 726.
23. Harhun MI, Gordienko DV, Povstyan OV, Moss RF, Bolton TB (2004). Function of interstitial cells of cajal in the rabbit portal vein. Circ Res 95 : 619 626.
24. i changes in interstitial cells of Cajal from rabbit portal vein. Cell Calcium 40 : 287 298.
25. Harhun M, Povstyan O, Gordienko D (2009). P2X Receptor-mediated current in myocytes from renal resistance arteries. J General Physiology 134 : 17.
26. Hughes S, Chan-Ling T (2004). Characterization of smooth muscle cell and pericyte differentiation in the rat retina in vivo. Invest Ophthalmol Vis Sci 45 : 2795 2806.
27. Hulsmann M, Nickel P, Kassack M, Schmalzing G, Lambrecht G, Markwardt F (2003). NF449, a novel picomolar potency antagonist at human P2X1 receptors. Eur J Pharmacol 470 : 1 7.
28. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ (2003). Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112 : 1895 1905.
29. Khakh BS, Proctor WR, Dunwiddie TV, Labarca C, Lester HA (1999). Allosteric control of gating and kinetics at P2X(4) receptor channels. J Neurosci 19 : 7289 7299.
30. Komlosi P, Fintha A, Bell PD (2006). Unraveling the relationship between macula densa cell volume and luminal solute concentration/osmolality. Kidney Int 70 : 865 871.
31. Le KT, Babinski K, Seguela P (1998). Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18 : 7152 7159.
32. Leonard BL, Navakatikyan MA, Malpas SC (2000). Differential regulation of the oscillations in sympathetic nerve activity and renal blood flow following volume expansion. Auton Neurosci 83 : 19 28.
33. Lewis CJ, Evans RJ (2000). Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels. Br J Pharmacol 131 : 1659 1666.
34. Lewis CJ, Evans RJ (2001). P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 38 : 332 340.
35. Loirand G, Pacaud P (1995). Mechanism of the ATP-induced rise in cytosolic Ca2+ in freshly isolated smooth muscle cells from human saphenous vein. Pflugers Arch 430 : 429 436.
36. McLaren GJ, Sneddon P, Kennedy C (1998). Comparison of the actions of ATP and UTP and P(2X1) receptors in smooth muscle of the rat tail artery. Eur J Pharmacol 351 : 139 144.
37. Malpas SC, Evans RG (1998). Do different levels and patterns of sympathetic activation all provoke renal vasoconstriction? J Auton Nerv Syst 69 : 72 82.
38. Malpas SC, Leonard BL (2000). Neural regulation of renal blood flow: a re-examination. Clin Exp Pharmacol Physiol 27 : 956 964.
39. Nicke A, Kerschensteiner D, Soto F (2005). Biochemical and functional evidence for heteromeric assembly of P2X1 and P2X4 subunits. J Neurochem 92 : 925 933.
40. Nishiyama A, Navar LG (2002). ATP mediates tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol 283 : R273 R275.
41. Nishiyama A, Majid DS, Taher KA, Miyatake A, Navar LG (2000). Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circ Res 86 : 656 662.
42. Nishiyama A, Majid DS, Walker M, III., Miyatake A, Navar LG (2001). Renal interstitial atp responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Hypertension 37 : 753 759.
43. Nori S, Fumagalli L, Bo X, Bogdanov Y, Burnstock G (1998). Coexpression of mRNAs for P2X1, P2X2 and P2X4 receptors in rat vascular smooth muscle: an in situ hybridization and RT-PCR study. J Vasc Res 35 : 179 185.
44. North RA (2002). Molecular physiology of P2X receptors. Physiol Rev 82 : 1013 1067.
45. North RA, Verkhratsky A (2006). Purinergic transmission in the central nervous system. Pflugers Arch 452 : 479 485.
46. Ralevic V (2009). Purines as neurotransmitters and neuromodulators in blood vessels. Curr Vasc Pharmacol 7 : 3 14.
47. Ralevic V, Burnstock G (1991). Roles of P2-purinoceptors in the cardiovascular system. Circulation 84 : 1 14.
48. Rettinger J, Schmalzing G, Damer S, Muller G, Nickel P, Lambrecht G (2000). The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor. Neuropharmacology 39 : 2044 2053.
49. Rettinger J, Braun K, Hochmann H, Kassack MU, Ullmann H, Nickel P et al. (2005). Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X1 receptor antagonist. Neuropharmacology 48 : 461 468.
50. Stehno-Bittel L, Sturek M (1992). Spontaneous sarcoplasmic reticulum calcium release and extrusion from bovine, not porcine, coronary artery smooth muscle. J Physiol 451 : 49 78.
51. Surprenant A, North RA (2009). Signaling at purinergic P2X receptors. Annu Rev Physiol 71 : 333 359.
52. Torres GE, Egan TM, Voigt MM (1999). Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274 : 6653 6659.
53. Turner CM, Vonend O, Chan C, Burnstock G, Unwin RJ (2003). The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 175 : 105 117.
54. Valera S, Hussy N, Evans RJ, Adami N, North RA, Surprenant A et al 1994). A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature 371 : 516 519.
55. Vanderwinden JM, Rumessen JJ, De Laet MH, Vanderhaeghen JJ, Schiffmann SN (1999). CD34+ cells in human intestine are fibroblasts adjacent to, but distinct from, interstitial cells of Cajal. Lab Invest 79 : 59 65.
56. Walsh MP (1994). Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 72 : 919 936.
57. 2+ signalling in rat arteries: ATP, noradrenaline and neuropeptide Y. Exp Physiol 94 : 31 37.
58. Wilkinson KD, Lee KM, Deshpande S, Duerksen-Hughes P, Boss JM, Pohl J (1989). The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246 : 670 673.
59. Yoshida T, Owens GK (2005). Molecular determinants of vascular smooth muscle cell diversity. Circ Res 96 : 280 291.